Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burger

Showing results (741-750 of 778) with videos related to

Pageof 78
Sort By:
American Journal of Medical Genetics. Part A|May 22, 2023
Recessive CHRM5 variant as a potential cause of neurogenic bladderSophia Schneider, Luca Schierbaum, Wessel A C Burger, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2019
Crystal structure of the M<sub>5</sub> muscarinic acetylcholine receptorZiva Vuckovic, Patrick R Gentry, Alice E Berizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Reply to S.A. UpadhyayaAlyssa T Reddy, Mark D Krailo, Allen B Buxton, et al.
Acta Neuropathologica|August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutationCheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology ConsortiumFaith G Davis, Beatrice S Malmer, Ken Aldape, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pediatric Blood & Cancer|July 1, 2010
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Robert W Sobol, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Cancer|August 14, 2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohortSun Young Rha, Eduardo Castanon, Sanjeev Gill, et al.
Pageof 78

Showing results (741-750 of 778) with videos related to

Sort By:
Pageof 78
American Journal of Medical Genetics. Part A|May 22, 2023
Recessive CHRM5 variant as a potential cause of neurogenic bladderSophia Schneider, Luca Schierbaum, Wessel A C Burger, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2019
Crystal structure of the M<sub>5</sub> muscarinic acetylcholine receptorZiva Vuckovic, Patrick R Gentry, Alice E Berizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Reply to S.A. UpadhyayaAlyssa T Reddy, Mark D Krailo, Allen B Buxton, et al.
Acta Neuropathologica|August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutationCheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology ConsortiumFaith G Davis, Beatrice S Malmer, Ken Aldape, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pediatric Blood & Cancer|July 1, 2010
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Robert W Sobol, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Cancer|August 14, 2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohortSun Young Rha, Eduardo Castanon, Sanjeev Gill, et al.
Pageof 78